Latest in Medicine

Institutional Rearing Associated With Psychopathology Risk in Children

Institutional Rearing Associated With Psychopathology Risk in Children

Children reared in an institution are found to have increased vulnerability to psychopathology diagnoses between childhood and adolescence.

Improved Outcomes With New Protocol for Treating Acute Ischemic Stroke

Improved Outcomes With New Protocol for Treating Acute Ischemic Stroke

Implementation of a physician-directed emergency stroke protocol resulted in decreased door-to-needle time and onset-to-treatment time.

FDA Panel Votes on Prucalopride for Chronic Idiopathic Constipation

FDA Panel Votes on Prucalopride for Chronic Idiopathic Constipation

The panel's decision was made based on data from from five Phase 3 studies and one Phase 4 trial which evaluated the safety and efficacy of prucalopride in patients with chronic constipation.

FDA Panel Votes on Drug/Device Combo to Treat Pain in Medically Supervised Setting

FDA Panel Votes on Drug/Device Combo to Treat Pain in Medically Supervised Setting

The FDA is not bound by the Committee's recommendation but takes it into consideration when making its decision.

AGA: New Opioid-Induced Constipation Management Guidelines Available

AGA: New Opioid-Induced Constipation Management Guidelines Available

The recommendations have been published in the AGA's official journal, Gastroenterology.

Treatment for Alagille Syndrome Granted Orphan Drug Designation

Treatment for Alagille Syndrome Granted Orphan Drug Designation

Alagille syndrome affects approximately 1 in 70,000 newborns.

Caffeine Consumption and Rosacea Risk: What's the Link?

Caffeine Consumption and Rosacea Risk: What's the Link?

Participants who responded to a question related to rosacea diagnosis in 2005 were included in the final analysis.

Talzenna Approved for Germline BRCA-Mutated, HER2-Negative Breast Cancer

Talzenna Approved for Germline BRCA-Mutated, HER2-Negative Breast Cancer

Talzenna, a poly (ADP-ribose) polymerase (PARP) inhibitor, was evaluated in EMBRACA, an open-label trial that randomized patients with gBRCAm HER2-negative locally advanced or metastatic breast cancer to receive talazoparib 1mg or physician's choice of chemotherapy.

Liletta Now Approved for Pregnancy Prevention for Up to 5 Years

Liletta Now Approved for Pregnancy Prevention for Up to 5 Years

The expanded approval was supposed by safety and efficacy data from the Phase 3 ACCESS IUS trial in women receiving Liletta.

Novel Intranasal Influenza Vaccine Shows Tolerability, Safety, and High Immune Response

Novel Intranasal Influenza Vaccine Shows Tolerability, Safety, and High Immune Response

NasoVAX, an adenovirus-based intranasal flu vaccine, shows tolerability, safety, and higher cellular immune response compared to an injectable vaccine.

Giving Flu Shots in Pharmacies Could Up Vaccination Coverage

Giving Flu Shots in Pharmacies Could Up Vaccination Coverage

Administering influenza vaccines through pharmacies in addition to traditional locations can increase vaccination coverage in the event of an epidemic.

Thoughts on Brain Death: The Last Time I Felt Like a Healer

Thoughts on Brain Death: The Last Time I Felt Like a Healer

Finding the balance of empathy and professionalism is a skill that not enough of us recognize as essential, and even fewer seek to teach.

Correctional Psychiatry: Challenges and Rewards

Correctional Psychiatry: Challenges and Rewards

Approximately 15% of incarcerated people have serious mental illness, although that number can vary depending on the type of illness.

Hand Hygiene Program Beneficial for Day Care Centers

Hand Hygiene Program Beneficial for Day Care Centers

An educational and hand hygiene program involving hand sanitizer can reduce the risk for respiratory infections for children attending day care centers.

Significant Mortality Reduction With Empagliflozin in T2D and CVD

Significant Mortality Reduction With Empagliflozin in T2D and CVD

Treatment with empagliflozin may positively impact life expectancy in patients with type 2 diabetes and cardiovascular disease.

Novel Blood Test for Irritable Bowel Syndrome Now Available

Novel Blood Test for Irritable Bowel Syndrome Now Available

The test works by measuring levels of anti-cytolethal distending toxin B (CdtB) and anti-vinculin, 2 biomarkers of post-infectious IBS-D and IBS-M.

Teacher, Student Psychological Well-being Linked

Teacher, Student Psychological Well-being Linked

Educators' mental health and well-being is associated with their students' mental well-being or feelings of distress.

Revcovi Approved for Adenosine Deaminase Severe Combined Immune Deficiency

Revcovi Approved for Adenosine Deaminase Severe Combined Immune Deficiency

The FDA approval was supported by data from 2 multicenter, open-label clinical trials (Study 1 [N=6] and Study 2 [N=4]).

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.

High Quality Care as Important as Universal Health Coverage in Reducing Global Mortality

High Quality Care as Important as Universal Health Coverage in Reducing Global Mortality

Universal health coverage has been proposed as a way of improving access to healthcare in low- and middle-income countries.

Free E-Newsletter